Eli Casdin - MergerLinks

Private EquityPrivateAcquisitionMinorityVenture Capital

Medical Services

target

INSITRO

bidder

Alexandria Venture Investments

£116m

38 dealmakers

MinorityAcquisitionVenture CapitalPrivatePrivate Equity

target

Kronos Bio

bidder

Perceptive Advisors

£118m

18 dealmakers

AcquisitionPrivate EquityMinorityPrivateVenture Capital

Health Care Services

target

Lyra Health

bidder

Addition Ventures

£83m

10 dealmakers

Venture CapitalAcquisitionPrivate EquityCross BorderPrivateMinority

target

Dna Script

bidder

Danaher Corporation

£75m

11 dealmakers

MajorityDomesticPrivateAcquisitionPrivate Equity

Health Care Services

target

Thrive Earlier Detection Corp

bidder

Exact Sciences

£1,651m

66 dealmakers

MinorityDomesticPrivate EquityAcquisitionPrivate

target

4d Molecular Therapeutics

bidder

Mirae Asset Financial Group

£56m

11 dealmakers

Private EquityPrivateMinorityAcquisitionVenture CapitalDomestic

target

Neurogene

bidder

Casdin Capital

£85m

14 dealmakers

Private EquityDomesticMergerMajorityPrivateReverse TakeoverDe-SPAC

target

Nautilus Biotechnology

bidder

Arya Sciences Acquisition Corp Iii

£654m

44 dealmakers

Reverse TakeoverPrivate EquityMajorityAcquisitionPrivateDomesticMergerDe-SPAC

Auto Technology

target

SEMA4

bidder

T. Rowe Price Group

£1,450m

44 dealmakers

DomesticPrivate EquityMinorityAcquisitionVenture CapitalPrivate

Medical Services

target

INSITRO

bidder

BLACKROCK

£287m

27 dealmakers

AcquisitionPrivate EquityDomesticVenture CapitalPrivateMinority

target

ABSCI

bidder

Casdin Capital

£90m

11 dealmakers

DomesticReverse TakeoverDe-SPACPrivate EquityPrivateAcquisitionMerger

target

SOMALOGIC

bidder

Janus Henderson Investors

£891m

63 dealmakers

PrivateVenture CapitalPrivate EquityMinorityAcquisitionCross Border

target

Century Therapeutics

bidder

Fidelity Management & Research Company

£115m

24 dealmakers

Private EquityDe-SPACReverse TakeoverPrivateDomesticMergerAcquisitionMajority

target

Tango Therapeutics

bidder

Cormorant Asset Management

£257m

32 dealmakers

MajorityAcquisitionVenture CapitalDomesticPrivate EquityPrivate

target

C2i Genomics

bidder

The Mark Foundation For Cancer Research

£72m

13 dealmakers

MinorityPrivatePrivate EquityCross BorderVenture CapitalAcquisition

target

Affinia Therapeutics

bidder

Casdin Capital

£80m

15 dealmakers

United Kingdom

AcquisitionPrivateMajorityPrivate EquityCross Border

target

INIVATA

bidder

NEOGENOMICS

£281m

41 dealmakers

MinorityDomesticVenture CapitalPrivateAcquisitionPrivate Equity

target

Dyno Therapeutics

bidder

Gv (google Ventures)

£71m

10 dealmakers

MajorityDomesticPrivatePrivate EquityAcquisitionReverse TakeoverDe-SPAC

target

Ginkgo Bioworks

bidder

Baillie Gifford & Co

£10,641m

107 dealmakers

Netherlands

MinorityVenture CapitalCross BorderPrivate EquityAcquisitionPrivate

target

Leyden Labs

bidder

Gv (google Ventures)

£34m

19 dealmakers

AcquisitionPrivateDomesticMinorityPrivate EquityVenture Capital

target

Nikang Therapeutics

bidder

Surveyor Capital

£141m

29 dealmakers

Ireland

Health Care Services

Private EquityPrivateAcquisitionCross BorderMinorityVenture Capital

target

LETSGETCHECKED

bidder

Transformation Capital Partners

£105m

12 dealmakers

AcquisitionCross BorderVenture CapitalPrivateMinorityPrivate Equity

target

Mnemo Therapeutics

bidder

Emerson Collective

£63m

6 dealmakers

MinorityVenture CapitalAcquisitionDomesticPrivatePrivate Equity

target

Prime Medicine

bidder

T. Rowe Price Group

£227m

17 dealmakers

Germany

Venture CapitalAcquisitionMinorityPrivate EquityCross BorderPrivate

target

T-KNIFE

bidder

Caas Capital Management

£79m

29 dealmakers

DomesticMajorityMergerPrivate EquityDe-SPACAcquisitionPrivateReverse Takeover

target

EQRX

bidder

Bvf Partners

£2,622m

53 dealmakers

DomesticVenture CapitalAcquisitionPrivatePrivate EquityMinority

Health Care Facilities

target

NEOGENOMICS

bidder

Avidity Partners

£144m

26 dealmakers

China

Venture CapitalAcquisitionMinorityCross BorderPrivate EquityPrivate

target

SHOUTI

bidder

Casdin Capital

£72m

20 dealmakers

Cross BorderPrivate EquityAcquisitionPrivateVenture CapitalMinority

target

Dna Script

bidder

Casdin Capital

£119m

28 dealmakers

Cross BorderMinorityPrivateVenture CapitalAcquisitionPrivate Equity

target

Sonoma Biotherapeutics

bidder

Casdin Capital

£190m

15 dealmakers

Venture CapitalPrivate EquityPrivateCross BorderAcquisitionMinority

target

Chroma Medicine

bidder

Atlas Venture

£93m

12 dealmakers

Cross BorderVenture CapitalAcquisitionPrivate EquityMinorityPrivate

target

Dna Script

bidder

EUREKARE

£148m

14 dealmakers

Private EquityDomesticVenture CapitalAcquisitionPrivateMinority

target

Maze Therapeutics

bidder

Driehaus Capital

£139m

12 dealmakers

Private EquityDomesticMinorityPublicAcquisition

target

FLUIDIGM

bidder

Casdin Capital

£184m

23 dealmakers

Canada

PrivatePrivate EquityVenture CapitalCross BorderMinorityAcquisition

target

Ventus Therapeutics

bidder

Andreessen Horowitz

£103m

12 dealmakers

AcquisitionVenture CapitalCross BorderPrivatePrivate EquityMinority

target

Moma Therapeutics

bidder

Rock Springs Capital

£121m

14 dealmakers

DomesticMinorityPrivate EquityAcquisitionPrivateVenture Capital

target

INVETX

bidder

F-prime Capital

£49m

13 dealmakers

MinorityPrivateCross BorderAcquisitionPrivate Equity

target

Celsius Therapeutics

bidder

Third Rock Ventures

£68m

3 dealmakers

Venture CapitalAcquisitionPrivatePrivate EquityCross Border

target

IDRX

bidder

Casdin Capital

£99m

7 dealmakers

Private EquityVenture CapitalPrivateAcquisitionDomesticMinority

Software

target

Komodo Health

bidder

Iconiq Capital

£192m

9 dealmakers

Venture CapitalPrivate EquityAcquisitionDomesticMinorityPrivate

Software

target

TRIALSPARK

bidder

Sequoia Capital

£138m

10 dealmakers

PrivateAcquisitionVenture CapitalPrivate EquityCross BorderMinority

target

ASIMOV

bidder

Kdt Ventures

£145m

8 dealmakers

Venture CapitalDomesticPrivate EquityAcquisitionPrivateMinority

target

Chroma Medicine

bidder

Arch Venture Partners

£111m

18 dealmakers

AcquisitionMinorityPrivate EquityPrivateVenture CapitalCross Border

target

SEPTERNA

bidder

Ra Capital Management

£116m

19 dealmakers